Category: General
GENERAL Natco Launches Generic Pomalidomide In US; Targets $3.2Bn Market

Natco Pharma, in partnership with Breckenridge Pharmaceutical, Inc., has announced the launch of Pomalidomide capsules in the United States, marking a significant expansion of its oncology and specialty portfolio in the world’s largest pharmaceutical market. The product is a generic version of Pomalyst, originally marketed by Celgene. Pomalidomide capsules are available in 1 mg, 2 […]

CW Bureau · Mar 3, 2026
GENERAL India’s API Industry Seen Growing 5–7% CAGR Through FY28: CareEdge

India’s Active Pharmaceutical Ingredient (API) industry, currently valued at an estimated $15–16 billion, is expected to grow at a compound annual growth rate (CAGR) of 5–7% through FY27 and FY28, according to a recent study by CareEdge Ratings. The projected growth is underpinned by supportive government policies, a structural shift towards high-potency and complex APIs, […]

CW Bureau · Mar 2, 2026
GENERAL PM Mitra Park Spurs Textile Push In TN With ₹2,192-Cr Investment

Tamil Nadu’s textile ambitions received a major push this week as the Board of Directors of PM Mitra Park Tamil Nadu Ltd cleared the allotment of 190.44 acres to 23 investors, unlocking a committed investment pipeline of ₹2,192.21 crore and a potential to generate 15,000 jobs. The decision, taken at the ninth board meeting chaired […]

CW Bureau · Mar 1, 2026
GENERAL India Tightens Aviation Vigil As Global Airspace Disruptions Escalate

As tensions flare in the Middle East following coordinated strikes on Iran by the United States and Israel, triggering a broader regional conflict, India has moved swiftly to safeguard its aviation ecosystem and protect passenger interests. The Union minister of civil aviation has undertaken a comprehensive review of the country’s aviation preparedness, convening a high-level […]

CW Bureau · Feb 28, 2026
GENERAL Medi Assist Expands Global Footprint, Seals Deal With LawtonAsia

Medi Assist Healthcare Services, India’s leading health benefits administrator, has announced a strategic partnership with LawtonAsia to enhance the member experience for policyholders across Southeast Asia. This collaboration represents a significant milestone in Medi Assist’s international expansion, enabling the deployment of its proprietary AI-enabled technology to improve how health benefits are delivered in new markets. […]

CW Bureau · Feb 27, 2026
GENERAL Private Hospitals Set For 14–15% Growth In FY27, Says Crisil Ratings

India’s private hospital sector is poised for another year of robust expansion, with revenues expected to grow 14–15% in fiscal 2027, marking the fifth consecutive year of double-digit growth, according to Crisil Ratings. The growth trajectory will be underpinned by sustained healthy occupancy levels, steady improvements in realisations and accelerated bed additions across leading hospital […]

CW Bureau · Feb 27, 2026
GENERAL Glenmark Bolsters North America Portfolio With New Product Launch

Glenmark Pharmaceuticals has announced the upcoming launch of Sodium Phosphates Injection USP in multiple single-dose vial presentations, further strengthening its institutional product portfolio in the North American market. The company will introduce Sodium Phosphates Injection USP in 15 mM P/5 mL, 45 mM P/15 mL and 150 mM P/50 mL (3 mM P/mL) single-dose vials, […]

CW Bureau · Feb 27, 2026
GENERAL Aptus Pharma Enters Critical Care Segment, Scales Up OTC Business

Gujarat-based Aptus Pharma is accelerating its transformation into a diversified healthcare player with a strategic expansion into life-saving injectables and ICU care products, while simultaneously strengthening its footprint in the fast-growing OTC and cosmeceutical segments. Building on its recent entry into the OTC and uro care space, the company has now set its sights on […]

CW Bureau · Feb 27, 2026
GENERAL Aurobindo Arm Eugia Secures USFDA Nod For Everolimus Tablets

Aurobindo Pharma has strengthened its US generics portfolio after its wholly owned subsidiary, Eugia Pharma Specialities, received final approval from the US Food and Drug Administration (USFDA) to manufacture and market Everolimus tablets in multiple strengths. The approval covers Everolimus tablets in 0.25 mg, 0.5 mg, 0.75 mg and 1 mg strengths. The product is […]

CW Bureau · Feb 26, 2026
GENERAL Zydus’ Novel Single-Pen Device Set To Redefine Semaglutide Therapy

Zydus Lifesciences is preparing to launch Semaglutide injection under the brand names SEMAGLYN, MASHEMA and ALTERME, following the patent expiry of the molecule in the country. The Drug Controller General of India (DCGI) has already granted approval for the manufacturing and marketing of Semaglutide injection for the treatment of Type 2 Diabetes Mellitus and obesity, […]

CW Bureau · Feb 25, 2026